1. Klose, Christoph S N, Mahlakõiv, Tanel, Moeller, Jesper B, Farber, Donna L, Artis, David. 2017. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. In Nature, 549, 282-286. doi:10.1038/nature23676. https://pubmed.ncbi.nlm.nih.gov/28869965/
2. Botticelli, Luca, Micioni Di Bonaventura, Emanuela, Del Bello, Fabio, Cifani, Carlo, Micioni Di Bonaventura, Maria Vittoria. 2023. The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior. In Pharmacological research, 195, 106875. doi:10.1016/j.phrs.2023.106875. https://pubmed.ncbi.nlm.nih.gov/37517560/
3. Tang, Yan, Hu, Chunsheng. 2021. NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma. In Disease markers, 2021, 5031479. doi:10.1155/2021/5031479. https://pubmed.ncbi.nlm.nih.gov/34336003/
4. Thompson, T A, Haag, J D, Gould, M N. . ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats. In Carcinogenesis, 21, 1917-22. doi:. https://pubmed.ncbi.nlm.nih.gov/11023551/
5. Chan, Maren M, Lu, Xin, Merchant, Faisal M, Iglehart, J Dirk, Miron, Penelope L. 2005. Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer. In Carcinogenesis, 26, 1343-53. doi:. https://pubmed.ncbi.nlm.nih.gov/15845649/